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The last 30 years, high frequency ventilation (HFV) has found its way from the neonatal to the paediatric
and adult ICU. With its small tidal volumes, strict intrathoracic pressure variations and disengagement of
ventilation from oxygenation, HFV ﬁts in our insights nowadays in lung protective ventilation. This
review provides you with an understanding of the different modes of HFV, gas exchange mechanisms
during HFV which uses tidal volumes below dead space volume, and some information on nursing and
weaning a child on HFV. Focus will be on the clinical use of high frequency oscillatory ventilation with
a practical overview of the strategies used: the high-volume strategy designed to rapidly recruit and
maintain optimal lung volume in diffuse alveolar disease and lung haemorrhage, the low volume strategy
in airleak, and the open airway strategy in small airway disease where the continuous distending
pressure is used to recruit and stent the airways.
 2009 Elsevier Ltd. All rights reserved.Educational aims
 To discuss the use of high frequency oscillatory ventilation
(HFOV) in the PICU
 To illustrate the different modes of high-frequency ventilation
 To understand the basic principles of gas exchange mecha-
nisms during HFOV
 To discuss the HFOV strategies most commonly used as
a (rescue) therapy in paediatric respiratory failure.
 To provide the reader with an algorithm of the open lung
approach during HFOV in diffuse alveolar disease.
 To emphasise the importance of lung protective ventilation in
children with acute respiratory failure and how HFOV ﬁts in
these insights.1. Introduction
Mechanical ventilation has come a long way since its ﬁrst
reference in 175 AD from Galen who used a bellows to inﬂate the
lungs of a deceased animal.1 While the exchange of oxygen and
carbon dioxide between blood and the alveolus works by diffusion
and requires no external work, air must be moved in and out to: þ32 3 281 34 71.
uval), dg.markhorst@vumc.nl
Vught).
All rights reserved.make it available to the gas exchange process. With the introduc-
tion of the iron lung during the polio pandemic, the age of practical
ventilation was started.2 Ventilators have evolved from simple
machines into microprocessor-controlled devices that allow
synchronization of a patient’s ventilatory demands.
Although often life-saving, mechanical ventilation has compli-
cations.3 Perhaps not surprisingly, the use of bellows in the early
days could easily rupture the lungs. Barotrauma refers to alveolar
and small airway destruction when high inspiratory pressures are
applied.4 Recently, the paradigm has shifted: volutrauma recog-
nizes that alveolar overdistension is more likely to occur as a result
of excessive volume and not pressure per se.5 In addition, there is
a large body of evidence indicating that ventilation at low lung
volume levels may contribute to injury. In diffuse alveolar disease
(DAD), the more dependent alveoli often reach a critical closing
volume at end-expiration, resulting in collapse followed by re-
opening during inspiration. The cyclic repetition of collapse and re-
opening generates shearing forces capable of causing damage,
hence the term atelectrauma.6 The injuries described here are
largely thought to be mechanical. Nevertheless, there is evidence
that mechanical factors can lead to injury that is cell and inﬂam-
matory mediator based. This biotrauma contributing to the genesis
of organ failure is related to exacerbation of inﬂammation and
locally produced cytokines.7
Mechanical ventilation can no longer be seen as a treatment
modality that simply supports the patient until the primary disease
resolves. Taken into account the above mentioned observations, it
seems logical to avoid both overstretching and cyclic closing and
Fig. 1. Volume–pressure relationship of the respiratory system indicating the zones of
ventilator reduced lung injury and the theoretical ‘‘safety zone’’.
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relation of the respiratory system a safe window, an area between
a lower zone of atelectasis and an upper zone of overdistension
(Fig. 1).8 Ideally, tidal volumes (VT) should ﬁt within this area by
setting the PEEP level above the lower inﬂection point and reducing
plateau pressures to avoid overinﬂation.9,10 In the disordered lung
the safe windowmay be too small to harbour the conventional tidal
volumes. High frequency ventilation (HFV) with its small VT, strict
intrathoracic pressure variations and disengagement of ventilation
from oxygenation, appears to be an ideal candidate for ventilation
within the safety zone.8,112. High frequency ventilation
There are different modes of HFV and each type has its own
unique advantages and disadvantages, but they are all character-
ized by a breathing frequency1 Hz (60 breaths/min) and VT lower
than dead-space volume.12 They can be classiﬁed in four types:
- high-frequency positive pressure ventilation (HFPPV)
- high-frequency jet ventilation (HFJV)
- high frequency ﬂow interrupter (HFFI)
- high-frequency oscillatory ventilation (HFOV).
HFV was introduced in the early 1970s, following the experi-
ences by Oberg and Sjo¨strand. They used higher frequencies and
smaller VT to eliminate the effect of respiratory variations on
carotid sinus reﬂexes. The increase in dead-space volume was
overcome by insufﬂating the gas directly into the trachea. They
ended with VTs of 3–4 mL/kg, high ﬂow rates and frequencies of
60–100 breaths/min. Expiration was passive, depending on lung
and chest wall elastic recoil. They called their method HFPPV.13
With newer speciﬁcally designed devices becoming popular, HFPPV
is rarely used nowadays.
HFJV was introduced by Sanders in 1967 to facilitate gas
exchange during bronchoscopy.14 Combining these and Sjo¨strands
observations, Klain and Smith introduced in 1977 high-frequency
transtracheal jet ventilation.15 Gas under high pressure or ‘‘jets’’were introduced through a small catheter placed in the tube. AVT of
2–5 ml/kg was delivered at high frequency (100–200 breaths/min).
The use of an associated continuous high ﬂow system permitted
entrainment of additional gas via the Venturi principle. A complex
interaction between jet velocity, inspiratory time, nozzle type and
system characteristics determined the volume of entrained gas.
Because this is not operator-controlled, it is difﬁcult to manipulate
with precision the VT delivered. Conventional breaths are some-
times used to aid in reinﬂating the lung. During HFJV, high ﬂow
rates prevent optimal humidiﬁcation, increasing the risk of
necrotising tracheobronchitis. As with HFPPV, expiration is passive.
Nowadays, HFJV is used primarily in situations requiring minimal
upper airway movement, such as laryngeal surgery.
HFFI is similar to HFJV but the gas control mechanism is
different. A rotating bar or ball with a small opening is placed in the
path of a high-pressure gas. As the bar or ball rotates, a small pulse
of gas is allowed to enter the airway. Expiration, again, is passive.
In 1980 Bohn et al. and Butler et al. demonstrated that adequate
gas exchange was possible by generating oscillations in the airways
at a frequency of 15 Hz.16,17 The oscillations could be generated
either by a loudspeaker or an electronically driven piston pump.
Earlier Lunkenheimer et al had found adequate ventilation in dogs
using frequencies of 20–40 Hz.18 This method was referred to as
HFOV since oscillations generated the required pressure swings.
The pressure oscillates around a constant distending pressure
(CDP) delivered via a continuous ﬂow which passes through
a variable restriction valve on the expiratory limb. This keeps the
lung volume stable and controllable. CDP in HFOV functions simi-
larly to CPAP in CMV in that it provides the pressure for alveolar
recruitment and thus regulates oxygenation. Ventilation in HFOV is
mainly dependent on frequency and VT2. As frequency decreases
the delivered VT increases because the longer respiratory cycle
allows a larger swing of the oscillating membrane. Therefore, at
a given power more CO2 is removed at lower frequencies. Gas is
pushed into the lung during inspiration, and actively pulled out
during expiration. Thus, both expiration and inspiration are active
processes.
3. Gas exchange mechanisms during HFV
One of the basic concepts taught in physiology is that for
adequate gas exchange VT should exceed the volume of the con-
ducting airways, known as dead space. Nevertheless, adequate
ventilation can be achieved during HFOV which generates VTs
smaller than dead space. Gas transport mechanisms other than
conventional bulk ﬂow must thus be involved.19 There are seven
potential mechanisms:
- direct ventilation of proximal alveoli
- turbulent ﬂow with lateral convective mixing
- Pendelluft ﬂow between adjacent areas of lung with varying
time constants for alveolar emptying
- Cardiogenic mixing due to distortion of lung units adjacent to
the contracting heart
- Asymmetric velocity proﬁles with air in the centre moving
fastest, entraining gas closer to the airway walls. This leads to
the streaming of ‘‘fresh’’ gas toward the alveoli and ‘‘alveolar’’
gas away from the alveoli along the outer wall.
- laminar ﬂow with lateral transport by diffusion (Taylor
dispersion)
- collateral ventilation through non-airway connections
between neighbouring alveoli.
Major gas transport mechanisms that work under physiologic
conditions in each region are shown in Fig. 2.20 Although all these
Fig. 2. Gas transport mechanisms during high-frequency ventilation. Reproduced with permission from: Slutsky, AS, Drazen, JM. Ventilation with small tidal volumes. N Engl J Med
2002; 347:631.
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precise quantitative contribution of each is unknown.
4. Clinical application
HFOV was used primarily and still most frequently in
neonates.21–25 In some of them HFOV is used as the ﬁrst-line
ventilator due to the high susceptibility of the premature lung to
injury. In 1994 Arnold published his results on the use of HFOV in
paediatrics.26 The following years much of the data on the appli-
cation of HFOV outside the NICU, came from case series.27–34 These
suggest that HFOV can be safely used and that its use is associated
with improvements in oxygenation and ventilation without wors-
ening air leaks. Despite high expectations, HFOV is still primarily
used as a rescue therapy in children with DAD and, to a lesser
extent, in children with air leak or small airway disease (SAD). DAD
patients primarily have oxygenation disturbances and a chest X-ray
with bilateral opacities (ARDS, lung contusion, pneumonia). SAD
patients usually have ventilatory problems with an increased
airway resistance and hyperinﬂation on chest X-ray.
HFOV as a rescue therapy is usually started when the following
criteria are met: ventilatory failure with plateau pressures of 30 cm
H2O despite the use of permissive hypercapnia for at least two hrs
(ventilatory failure) or an oxygenation index 13 demonstrated by
two blood gas measurements over a six-hr period (oxygenatory
failure). However, at times the decision to start HFOV is earlier,
based on clinical judgement. Taken into account that a small
number of RCTs in paediatric or adult HFOV support the suggestion
that HFOVmay be more successful if applied earlier in the course of
the disease, this approach might be justiﬁed.26,35,36
Depending on the underlying condition, three different strate-
gies can be used:
- the high-volume or open lung strategy designed to rapidly
recruit and maintain optimal lung volume in DAD and lung
haemorrhage (Fig. 3). The initial CDP is set 3–5 cm H20 above
themean airway pressure (MAP) during CMVwith a FiO2 of 1.0.
The aims are a SaO2 90% at an FiO2 0.4, a pH above 7.25
irrespective of PaCO2, and stable hemodynamics. To optimally
recruit the lung, CDP is increased in steps of 2 cm H20 withsubsequent decreases of FiO2 until the oxygenation target is
reached. Usually a frequency of 10 Hz is used in children
<10 kg, 8 Hz in children >10 kg. The amplitude (dP) is initially
set to achieve adequate chest wall vibration and sequentially
adjusted to achieve the ventilatory target. If respiratory
acidosis persists with maximal dP, frequency is decreased. A
more appropriate approach would be to set power at
maximum and adjust frequency downward until adequate
chest wall vibration is achieved. This would achieve ventilatory
support at the smallest VT possible,37,38 but this practice has not
yet gained widespread acceptance. It has also been known for
years that recruitment manoeuvres are needed to reverse
atelectasis. Although recent studies have demonstrated the
safety and efﬁcacy of such manoeuvres in adults, they are not
routinely used in the PICU yet. Fig. 3 points out at which steps
recruitment manoeuvres might be considered.
- the low volume strategy in air leak where, after an initial iden-
tical approach as in the open lung strategy, CDP is reduced until
the air leak ceases. Lower SaO2 and higher oxygen supply is
accepted (permissive hypoxemia)
- the open airway strategy in SAD where CDP is used to recruit
and stent the airways. One starts with an FiO2 of 1.0 and CDP set
2 cm higher than MAP on CMV. If necessary, CDP is increased
according to SaO2 and, in contrast to the ‘‘open-lung’’ strategy,
also in regard to PaCO2. Since the CDP is applied throughout the
entire respiratory cycle, airways open, their diameter stabilises
and resistance during expiration decreases. The limiting ﬂow is
dependent on small airway diameter, which is dependent on
lung volume, thus at higher lung volume ﬂow limitation can be
minimised. In addition, open small airways enable a better
propagation of the oscillations down to the alveolus. CDP thus
has an inﬂuence on ventilation. The active expiratory phase
assists further with moving gas from the alveoli.28,29 Once the
airways are opened, careful attention must be paid to over-
inﬂation since the normal compliant alveoli are faced with
relatively high CDP. For the same reason, additional recruit-
ment manoeuvres are not performed. Every incremental
change in CDP should be followed by PaCO2 determination to
see at which CDP the airways open and PaCO2 decreases.
Overdistention is suspected if the circulation becomes
SaO2>85% or PaO2>50mmHg SaO2<85% or PaO2<50mmHg
Step 4: Obtain Chest X-Ray
Low Inflation Volume Normal or High Inflation Volume
Optimize circulation
back to step 2
Decrease CDP 1 cmH2O
If oxygenation deteriorates return to previous CDP
Step 5: wait for 48 hrs, reconsidering every 8 hrs step2 
until oxygenation failure criteria are met: OI 42 or doubled since entry
OR
repeat RM. If no response increase FiO2 in steps to 1.0,  increase
CDP slowly to meet goal
Perform RM. If no response increase
FiO2 to 1.0,  increase CDP slowly to meet
goal
If oxygenation stil deteriorates
HFOV transition failure
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Fig. 3. Algorithm of the open lung approach in diffuse alveolar disease. RM¼ recruitment manoeuvre; CDP¼ continuous distending pressure.
E.L.IM. Duval et al. / Respiratory Medicine CME 2 (2009) 155–161158compromised, this can be restored by lowering CDP or ﬂuid
administration. The degree of lung hyperinﬂation on chest
X-ray is not used to modify CDP.
Based on the positive experiences in paediatrics and with
evolving technology, HFOV has now found its way into adult
intensive care as well.35,39–41
5. Nursing a child on HFOV
There are a number of aspects that should be highlighted. The
sight of someone being ‘oscillated’ can be disturbing for the
family, it is therefore essential to provide adequate information.
After a patient has been attached to an oscillator, careful obser-
vation for the vibration pattern (the chest wiggle factor)constitutes the most reliable clinical measure which may reveal
early evidence of changing lung disease or adverse effects. If
chest wiggle diminishes, the ET tube might have slipped down or
became obstructed. One sided chest wiggling may indicate
a pneumothorax. Auscultation during HFOV may be difﬁcult, but
not useless. Reduced breath sounds can indicate one-sided
ventilation by either a tube too low, or a pneumothorax.42 One
can also listen to the intensity or sound the piston makes.
However, what sounds one is supposed to hear is debated and
any accurate interpretation requires appropriate training. Suc-
tioning for the ﬁrst 24 h is usually not necessary. When using
a closed system, it is important to draw back the catheter all the
way on completion. Alarm limits must be set within safe
boundaries (usually 3–5 above and below the desired CDP).
When positioning a patient, at least two nurses should assist
Practice points
 High frequency ventilation with its small VT, strict
intrathoracic pressure variations and disengagement of
ventilation from oxygenation, appears to be an ideal
candidate for ventilation within the safety zone
 In contrast to most other modes of HFV, expiration
during HFOV is an active process.
 The earlier use of HFOV seems to be more beneficial
 RCTs in children and adults have emphasized ‘‘aggres-
sive’’ lung volume recruitment during HFOV
 A more appropriate approach with the power set at
maximum and frequency adjusted downward until
adequate chest wall vibration is achieved, would
support ventilation at the smallest VT possible.
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to prevent necrotizing tracheobronchitis.
6. Weaning
Weaning should not be delayed unnecessarily, nor should it
be done prematurely. Unfortunately, there is no speciﬁc criteria
that generalizes to all children. The level of CDP might be more
likely a range than just one value. Generally, weaning may be
considered when CDP is at least reduced to 17 cm H20, FiO2 to
0.4, and the patient tolerates suctioning. Often the child
demonstrates satisfactory gas exchange on CMV on a MAP several
cm below the last CDP on HFOV. It is possible to successfully
extubate a child directly from HFOV. However, older children
often don’t tolerate tapering of sedation that allows spontaneous
breathing on an oscillator, and their spontaneous breathing may
signiﬁcantly depressurize the circuit, leading to alarms or even
ventilator shutdown.
7. About smart ventilators, and the people who use them
Rest is undoubtedly, the best way to heal an injury and this is
also true for the lungs.43 The less the lungs are forced to expand-
collapse, the less likely a lung injury is. The question nowadays
is: should we move towards tidal volumes as small as possible
without permitting the lung to deﬂate at all? This can be ach-
ieved using HFOV. Although the oscillations may cause signiﬁcant
pressure swings in the tube, the pressure ﬂuctuations are
signiﬁcantly attenuated at the alveolar level.44 This helps protect
the alveoli from volutrauma.8 By optimizing recruitment and
ventilation perfusion matching, the use of HFV also allows
reductions in oxygen to less toxic levels. Theoretically HFOV
provides the ultimate open lung strategy, preserving end expi-
ratory lung volume, minimizing cyclic stretch, and avoiding
parenchymal overdistention by limiting VT and transpulmonary
pressure.45
Such is the promise of HFOV, but like many other promises, it
has been hard to fulﬁl. Although animal studies clearly demon-
strated less pulmonary damage using HFOV compared to CMV,
clinical trials are less unequivocal. This may be due to the wide
range of aetiologies of acute respiratory failure in the PICU, together
with a gradual trend toward the use of more protective conven-
tional ventilation strategies. Although none of the paediatric RCTs
demonstrated any survival beneﬁt, they were all underpowered to
do so. Nevertheless, children treated with HFOV demonstrated
improvements in oxygenation, were exposed to less oxygen and
had less chronic lung disease.22–26,36,46–48 All trials that demon-
strated an oxygenation beneﬁt with HFOV have emphasized lung
volume recruitment.23,24,26,36
In a cumulative meta-analysis it was shown that, over time,
CMV treatment improved, diminishing the relative beneﬁt of
HFOV.49 It turned out that the way how the ventilator was used
had more impact on pulmonary outcome, than the type of
ventilator. For patients with lung injury, the ventilation strategy
should be based on low VTs, with a relatively fast rate, with or
without more generous PEEP has heretofore been given.
Nevertheless, Rubenfeld et al showed that despite the widely
accepted data on lung protective ventilation (LPV), most patients
with ARDS are currently not managed with LPV during CMV.50
HFOV not only perfectly ﬁts in our insights nowadays in LPV, but
it has the potential to remove most barriers to its use in criti-
cally ill patients. HFOV is easy to work with, oxygenation and
ventilation are independently regulated, and it is at least as safe
and efﬁcient as CMV in children of all ages and with different
diseases, provided certain strategies are followed. An importantlesson learned along the years of development of HFOV is that it
is much easier to introduce a laboratory technology in clinical
practice than it is to reach consensus on how to use it. The next
step in the story will be to evaluate a better HFOV protocol (i.e.
with volume recruitment manoeuvres and higher frequencies)
against whatever is the best conventional alternative at the
time.Conﬂict of interest statement
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Answer the following questions: true/false
1. With regard to ventilator induced injury
a. Barotrauma refers to great airway destruction
b. Ventilation at low lung volume may contribute to lung
injury
c. Atelectrauma occurs most often in the non-dependent
alveoli
d. Ventilator induced injury may lead to multi-organ failure
e. High-frequency ventilation has strict intrathoracic pressure
variations
2. Different modes of high-frequency ventilation
a. In HFPPV, expiration depends on lung and chest wall elastic
recoil
b. In HFJV, the volume of entrained gas (which determines the
VT delivered) is operator controlled
c. In HFOV oscillations are generated at a frequency of 50
breaths/min
E.L.IM. Duval et al. / Respiratory Medicine CME 2 (2009) 155–161160d. In HFOV, the delivered VT decreases with increasing
frequency
e. In HFFI both inspiration and expiration are active processes
3. Gas exchange mechanism during HFOV
a. conventional bulk ﬂow ventilation does not take place
b. pendelluft takes place due to heterogeneity in the diseased
lung areas
c. VT is<VD
d. The contracting heart augments gas exchange during HFOV
e. Taylor dispersion relates to collateral ventilation
4. Clinical use of HFOV
a. paediatric case series suggest that HFOV can be safely and
effectively used in acute respiratory failure
b. The use of HFOV in children can only be propagated as
a rescue therapy after failure of conventional ventilation
due to the high risk of air leak
c. Permissive hypoxemia might be justiﬁed in the low volume
strategy for SAD
d. The open lung strategy aggressively recruits the lung in
which the FiO2 need functions as a hallmark
e. Maximum power with the highest frequency to achieve
good chest wall vibration, will result in ventilation at the
smallest VT
5. Nursing and weaning
a. unilateral wiggling of the chest can indicate
a pneumothorax
b. cardiac auscultation is not possible during HFOV
c. when CDP is 17 cm H20 with a FiO2 0.4, the child must
be transitioned back to CMV
d. suctioning is usually not necessary the ﬁrst 24 h
e. in transitioning the child back to CMV, the MAP on CMV
should be at the same level of the last CDP on HFOV
6. Smart ventilators
a. There is an attenuation of pressure swings down the
endotracheal tube, which ﬁts in the insights of LPV
nowadays.
b. HFOV has the advantage of disengagement of ventilation
from oxygenation
c. The paediatric RCTs showed a small survival beneﬁt in the
HFOV group compared to the conventionally ventilated
group
d. Children treated with HFOV showed less chronic lung
disease
e. A cumulative meta-analysis showed that the way how the
ventilator was used had more impact on pulmonary
outcome, than the type of ventilatorReferences
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